Coronary CTA for Assessing CAD - Are We There Yet?

Matthew Budoff

Cardiogenic Shock - The Team Approach

Faisal Rahman

Cholesterol Treatment Decisions: Recent Updates to Guidelines and St…

Gary Martin

Beyond 10-Year Risk: New Paradigms for Long-Term Risk Estimation Wit…

Heart in Diabetes (HiD)

S. Khan

Combination Therapy with SGLT2 Inhibitors and GLP-1 Receptor Agonist…

Alessandro Doria

Chest Pain in Emergency Department Settings

University Hospitals

G. Rao, R. Hughes

RV Function on 2D Echo

Rabia Arshad

The Best of AHA23 for the Primary Care Doctor

Cecilia Bahit

An Efficient Approach to Addressing Syncope in the Office

Dr. Vu Kiet Tran

V. Tran

Social Determinants of Health for Cardiovascular Kidney Metabolic Sy…

Kibret Enyew Belay

I Have a Carrot and a Stent, You Pick!

Koushik Reddy

New Generation of Stents Are Needed for Renal Vein Stenting

Transformative Endovascular Decisions Conference

M. Razavi

The 'Familial' in Familial Hypercholesterolemia

Samuel Gidding

Physical Activity and Cardiorespiratory Fitness as Modulators of Hea…

Barry A. Franklin

SGLT2 Inhibitors: A Therapy for All Patients With Heart Failure

San Diego Heart Failure Symposiums

C. Yancy

Treating Hypertension: Goals and New Strategies for Achieving Them

San Diego Heart Failure Symposiums

J. H. Ix

Managing Iron Deficiency in Heart Failure: Recognizing the Need for …

Craig Beavers

Intravenous Iron for Heart Failure: Where Is the Evidence?

28th Annual Heart Failure 2024: An Update on Therapy

I. Pina

The Cardiometabolic Syndrome: A New Framework for Understanding Hear…

San Diego Heart Failure Symposiums

P. Taub

Controlling Blood Pressure in the Patient with HFpEF

MUSC Cardiology

J. Basile